UPDATE: Allergan (AGN) Said in Advanced Talks to Buy U.K.'s Kandy - Bloomberg

---

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

---

(Updated - January 25, 2018 7:44 AM EST)

Allergan (NYSE: AGN) is in advanced talks to acquire U.K.'s Kandy Therapeutics, according to Bloomberg, citing people with knowlege of the matter. Kandy could be valued at more than $400 million based on upfront and milestone payments.

An agreement could be reached soon, but other suitors may still emerge.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Apollo (APO) Said To Show Early Interest In Manchester United (MANU) Stake - Bloomberg
• Laird Superfood, Inc. (LSF) Confirms Receipt of Unsolicited Offer for $3 Per Share
• Brooge Energy (BROG) Announces Acquisition Proposal from its Majority Shareholder